Hub : Traits :

Smoking Status

623 significantly associated models · 188 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 7715776 9571422 2 1 1.9e-09 1.4e-08 5.6e-02 89 RERE
2 1 31494475 32929175 1 1 4.9e-08 1.8e-08 1.0e+00 100 BAI2
3 1 33030461 34592020 2 1 3.8e-09 2.9e-09 1.0e+00 100 PHC2
4 1 43152610 45137893 4 2 8.2e-10 1.4e-13 2.8e-03 84 DPH2 ST3GAL3
5 1 45560561 47193058 1 1 3.4e-07 3.0e-07 1.6e-05 29 MAST2
6 1 48301764 51567474 2 1 2.6e-08 1.9e-11 4.9e-05 63 AGBL4
7 1 153260711 155248575 4 4 7.2e-12 1.3e-11 8.7e-01 100 CHRNB2 HAX1 RAB13
8 2 43417083 45864710 2 2 5.1e-19 8.5e-19 1.0e+00 100 LRPPRC RP11-89K21.1
9 2 47224927 48727280 1 1 2.2e-07 4.3e-06 8.5e-01 100 MSH6
10 2 161297929 162790882 1 1 3.1e-09 7.0e-09 4.9e-03 76 TANK
11 3 24941038 26396178 1 1 1.8e-08 1.4e-08 1.0e-08 -2 TOP2B
12 3 48012797 51043528 25 7 6.4e-11 2.8e-09 NaN NaN AMIGO3 GPX1 HYAL3 MST1R NAT6
13 3 51616334 53778875 12 1 1.3e-08 3.3e-09 4.4e-02 88 GLYCTK-AS1
14 3 84317575 86808226 1 1 1.9e-09 4.7e-18 4.2e-10 48 CADM2
15 5 59353199 61145102 3 1 2.4e-08 9.3e-10 3.6e-03 77 ELOVL7
16 5 86867897 88875673 2 2 6.1e-08 1.7e-09 7.5e-01 100 MEF2C TMEM161B-AS1
17 5 169590807 171533656 2 1 3.6e-08 9.7e-09 1.0e+00 100 NPM1
18 6 36751245 38162310 2 1 1.2e-08 4.4e-09 9.7e-04 68 CCDC167
19 6 100257579 102026932 2 1 3.3e-07 2.2e-07 3.7e-02 84 RP3-467N11.1
20 6 110588546 112621834 5 1 1.9e-19 2.1e-20 8.0e-03 92 GTF3C6
21 7 1181139 2580275 1 1 2.6e-09 5.2e-10 2.4e-02 87 AC110781.3
22 7 2646223 5003373 1 1 8.2e-09 1.6e-11 3.8e-06 53 SDK1
23 7 98244565 99751521 3 1 1.7e-09 6.2e-09 4.2e-01 98 CPSF4
24 7 109603832 111895681 1 1 2.2e-07 1.6e-07 1.0e+00 100 IMMP2L
25 7 116660803 118518479 2 2 7.9e-14 5.0e-14 1.0e+00 100 CTTNBP2 NAA38
26 8 26648746 28100234 1 1 1.2e-10 9.9e-24 1.2e-14 41 EPHX2
27 8 65812899 67199420 1 1 1.9e-07 4.4e-07 3.3e-02 82 CTD-3025N20.3
28 8 91282507 92689456 1 1 3.3e-08 1.9e-10 9.9e-04 73 RP11-122A3.2
29 9 2208793 3753025 1 1 7.4e-08 3.2e-11 3.9e-07 42 CARM1P1
30 9 126927285 129422783 9 7 6.1e-15 1.1e-13 NaN NaN GAPVD1 MAPKAP1 PPP6C
31 10 10349662 12076043 1 1 2.7e-09 2.8e-07 5.8e-02 86 CELF2
32 10 21087485 22724472 2 1 3.8e-08 4.3e-08 2.4e-01 95 CASC10
33 10 102152297 105910221 21 3 2.3e-22 1.3e-22 3.4e-02 95 ACTR1A TLX1NB WBP1L
34 11 16343081 18106069 3 1 1.3e-09 3.1e-10 7.8e-03 82 PIK3C2A
35 11 26818083 28416646 2 2 1.8e-07 2.0e-15 8.4e-10 40 BDNF-AS LIN7C
36 11 63417724 65186348 2 2 1.6e-07 6.0e-07 3.7e-01 97 CCDC88B NRXN2
37 11 112135760 113846006 2 1 6.7e-14 3.6e-43 7.9e-32 27 NCAM1
38 12 55444736 57125879 5 1 6.8e-09 6.8e-08 8.8e-02 90 SUOX
39 12 108342014 109820777 1 1 1.1e-07 2.4e-07 1.8e-01 93 CORO1C
40 12 119870094 122037099 6 2 7.7e-10 3.1e-09 1.6e-01 94 COQ5 UNC119B
41 14 103289637 105211221 6 7 1.2e-09 2.5e-09 NaN NaN KLC1 PPP1R13B TDRD9 XRCC3
42 15 46780520 48764942 1 1 8.1e-13 3.8e-17 1.4e-09 48 SEMA6D
43 15 67138238 68789191 1 1 1.7e-07 3.4e-07 1.0e-02 74 MAP2K5
44 15 83167559 84478679 2 1 3.4e-07 6.0e-07 1.1e-02 74 RP11-382A20.2
45 15 90730363 92135418 1 1 2.3e-07 7.1e-06 3.2e-01 95 FES
46 16 86671 1488646 13 1 1.5e-11 2.7e-11 1.8e-01 96 WDR24
47 16 30347731 31720486 1 1 4.5e-08 2.1e-07 6.9e-05 41 STX1B
48 16 69062879 70725815 3 2 1.4e-10 4.8e-11 2.0e-01 96 NOB1 PDXDC2P
49 16 74989340 76385874 1 1 1.5e-07 7.7e-09 1.4e-06 30 TERF2IP
50 17 1263564 2923933 2 1 1.1e-10 1.3e-09 3.9e-02 88 SRR
51 17 37137299 38547868 1 1 8.4e-08 8.2e-08 4.7e-02 86 PGAP3
52 18 69836 907710 1 1 5.7e-08 9.5e-09 3.5e-02 87 USP14
53 20 30591354 32029439 1 1 1.7e-08 1.2e-10 7.2e-05 62 COMMD7
54 20 61576647 62912463 2 1 8.6e-08 9.5e-06 1.0e-01 86 RTEL1
55 22 41181586 43674249 9 3 5.1e-11 4.0e-10 2.1e-01 96 CYP2D8P1 DESI1 RRP7A
56 22 45736153 47135205 1 1 1.6e-08 3.3e-08 8.5e-02 90 LINC00899

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Crohns Disease (2017) 1.60 5 3 9.1 -0.40 5.1e-01 CCDC88B FES MST1R PGAP3 RTEL1
Irritable Bowel Disease (IBD) 2.07 6 3 9.1 -0.43 4.0e-01 CCDC88B FES GPX1 MST1R PGAP3 RTEL1
Ulcerative Colitis (UC) 2.21 4 4 12.1 -0.71 2.9e-01 GPX1 MST1R PGAP3 RTEL1
Major Depression (MDD) 2.91 1 0 0.0 0.00 1.0e+00 GPX1
Reaction Time 1.81 3 1 3.0 0.00 1.0e+00 AGBL4 COMMD7 RERE
Verbal and Numeric Reasoning (VNR) 2.25 7 3 9.1 -0.62 1.3e-01 AMIGO3 GLYCTK-AS1 GPX1 MST1R ST3GAL3 SUOX TANK
Breast Cancer 1.04 2 1 3.0 0.00 1.0e+00 CASC10 MAST2
Ovarian Cancer 1.13 1 1 3.0 0.00 1.0e+00 CASC10
Prostate Cancer 2.11 1 0 0.0 0.00 1.0e+00 WBP1L
Age at First Birth 3.24 4 2 6.1 0.15 8.5e-01 AMIGO3 GPX1 MST1R NAT6
Bipolar Disorder 2.15 1 0 0.0 0.00 1.0e+00 GLYCTK-AS1
Body Mass Index (BMI) (2010) 2.06 4 0 0.0 0.91 9.4e-02 BDNF-AS LIN7C MAP2K5 TLX1NB
Crohns Disease (2012) 1.68 4 1 3.0 0.50 5.0e-01 CCDC88B MST1R PGAP3 RTEL1
HDL Cholesterol 1.30 1 1 3.0 0.00 1.0e+00 PGAP3
Neuroticism 1.83 1 0 0.0 0.00 1.0e+00 TANK
Primary Biliary Cirrhosis 1.25 2 1 3.0 0.00 1.0e+00 CCDC88B PGAP3
Schizophrenia 3.13 13 7 21.2 0.45 8.9e-02 AC110781.3 ACTR1A DPH2 FES GLYCTK-AS1 IMMP2L KLC1 PIK3C2A PPP1R13B RERE ST3GAL3 TDRD9 XRCC3
Ulcerative Colitis 2.36 4 3 9.1 0.49 5.1e-01 COMMD7 MST1R PGAP3 RTEL1
Blood Eosinophil Count 1.19 16 7 21.2 0.11 6.7e-01 BDNF-AS CCDC88B DESI1 GLYCTK-AS1 GPX1 HYAL3 LIN7C MAP2K5 MST1R PGAP3 PHC2 RERE SUOX TDRD9 UNC119B XRCC3
Blood Platelet Count 0.89 20 11 33.3 0.35 1.3e-01 CCDC167 COMMD7 CORO1C CPSF4 CTD-3025N20.3 CYP2D8P1 GLYCTK-AS1 MAST2 MEF2C MSH6 PGAP3 PHC2 PIK3C2A RP11-382A20.2 RTEL1 ST3GAL3 TOP2B UNC119B WBP1L WDR24
Blood Red Count 1.35 20 13 39.4 0.07 7.6e-01 AMIGO3 COMMD7 ELOVL7 FES GLYCTK-AS1 GPX1 GTF3C6 HAX1 KLC1 MAPKAP1 MAST2 MEF2C PGAP3 RAB13 RTEL1 ST3GAL3 SUOX TDRD9 UNC119B XRCC3
Blood White Count 2.24 15 10 30.3 0.66 2.8e-03 ACTR1A CPSF4 FES KLC1 MST1R PGAP3 PPP1R13B RERE RTEL1 SEMA6D SRR TDRD9 TMEM161B-AS1 WBP1L XRCC3
Heel T-Score 2.31 14 11 33.3 0.10 6.8e-01 AMIGO3 BDNF-AS CCDC88B GPX1 HYAL3 KLC1 LINC00899 MSH6 NCAM1 PPP1R13B RERE SRR TDRD9 XRCC3
BMI 3.53 32 24 72.7 0.82 2.0e-09 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GLYCTK-AS1 GPX1 GTF3C6 HYAL3 KLC1 LIN7C MAP2K5 MAST2 MEF2C MST1R NAT6 NOB1 NPM1 NRXN2 PHC2 PPP1R13B RP3-467N11.1 RTEL1 SRR STX1B SUOX TDRD9 TLX1NB XRCC3
Height 1.24 27 21 63.6 -0.63 1.2e-04 AMIGO3 COQ5 CPSF4 DESI1 FES GAPVD1 GLYCTK-AS1 GPX1 HYAL3 KLC1 LINC00899 MAPKAP1 MAST2 NCAM1 NOB1 PHC2 PIK3C2A PPP1R13B PPP6C RP11-122A3.2 RRP7A ST3GAL3 TDRD9 TLX1NB WBP1L WDR24 XRCC3
Waist Hip Ratio (WHR) 1.57 9 5 15.2 -0.21 4.9e-01 AMIGO3 CCDC88B GAPVD1 GLYCTK-AS1 GPX1 MAPKAP1 MSH6 PPP6C SEMA6D
Systolic Blood Pressure 2.56 17 9 27.3 -0.57 1.0e-02 AC110781.3 ACTR1A CADM2 CCDC167 COQ5 FES GAPVD1 HAX1 LIN7C MAPKAP1 PDXDC2P PIK3C2A PPP6C RERE RP11-122A3.2 SRR TLX1NB
Allergy or Eczema 1.98 6 6 18.2 0.22 6.8e-01 PGAP3 RERE RTEL1 SUOX UNC119B WBP1L
Cardiovascular Disease 2.16 10 2 6.1 0.35 2.4e-01 CCDC88B FES KLC1 MAP2K5 MAPKAP1 PDXDC2P PPP1R13B SUOX TDRD9 XRCC3
Hypothyroidism (self reported) 1.62 4 3 9.1 0.23 7.7e-01 CCDC88B RERE SUOX TANK
Respiratory disease 2.79 6 3 9.1 0.41 4.1e-01 MAP2K5 MST1R PGAP3 RERE RTEL1 SUOX
Type 2 Diabetes (T2D) 1.52 1 0 0.0 0.00 1.0e+00 MST1R
Lung FEV1/FVC ratio 1.36 13 4 12.1 0.02 9.4e-01 ACTR1A CASC10 COMMD7 CORO1C CTTNBP2 GPX1 HYAL3 MSH6 RAB13 RERE SUOX TLX1NB TOP2B
Lung FVC 1.63 14 9 27.3 -0.27 3.4e-01 AC110781.3 CASC10 GPX1 LIN7C MAP2K5 MSH6 NOB1 PDXDC2P PGAP3 RTEL1 STX1B SUOX UNC119B USP14
Neuroticism 2.45 10 2 6.1 0.10 7.7e-01 CADM2 CTTNBP2 GAPVD1 GLYCTK-AS1 GPX1 MAP2K5 PPP6C RERE RP11-122A3.2 TMEM161B-AS1
Chronotype (morning person) 2.24 7 0 0.0 -0.70 8.2e-02 BDNF-AS CYP2D8P1 DESI1 GPX1 LIN7C MST1R TMEM161B-AS1
Hair Pigment 0.22 7 5 15.2 0.98 3.5e-06 FES KLC1 MSH6 PPP1R13B SUOX TDRD9 XRCC3
Tanning 0.28 4 1 3.0 0.94 1.7e-02 CADM2 COMMD7 GLYCTK-AS1 MAPKAP1
Hand grip strength (left) 1.96 8 2 6.1 -0.14 7.5e-01 ACTR1A CADM2 GAPVD1 MAPKAP1 NOB1 PHC2 PPP6C TLX1NB
Number of treatments/medications taken 2.08 5 1 3.0 -0.67 2.2e-01 CASC10 COMMD7 FES MST1R TANK
Sensitivity / hurt feelings 1.91 2 0 0.0 0.00 1.0e+00 GAPVD1 MAPKAP1
Frequency of depressed mood in last 2 weeks 1.83 1 0 0.0 0.00 1.0e+00 CELF2
Hearing difficulty/problems: Yes 1.56 1 0 0.0 0.00 1.0e+00 MAST2
Relative age of first facial hair 1.97 4 0 0.0 -1.00 5.7e-04 DPH2 GPX1 HYAL3 MST1R
Ever had hysterectomy (womb removed) 1.25 1 0 0.0 0.00 1.0e+00 CASC10
Systolic blood pressure, automated reading 2.29 6 4 12.1 0.61 2.0e-01 FES GAPVD1 MAPKAP1 PDXDC2P RERE SRR
Angina 1.56 1 1 3.0 0.00 1.0e+00 FES
Medication: Co-codamol 1.70 2 0 0.0 0.00 1.0e+00 AMIGO3 MST1R
Diabetes (mother) 1.29 1 0 0.0 0.00 1.0e+00 COQ5
Pack years adult smoking proportion 3.45 6 1 3.0 -0.99 3.8e-05 AGBL4 GPX1 KLC1 PPP1R13B SEMA6D XRCC3
Impedance of leg (right) 2.29 24 10 30.3 0.59 1.3e-03 ACTR1A AMIGO3 BDNF-AS CADM2 CPSF4 FES GAPVD1 GLYCTK-AS1 GPX1 HYAL3 KLC1 LIN7C MEF2C MST1R NAT6 NPM1 PHC2 PIK3C2A PPP1R13B PPP6C SEMA6D SUOX TDRD9 XRCC3
Leg fat-free mass (left) 1.98 20 10 30.3 -0.28 2.2e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 DESI1 GAPVD1 GPX1 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 PPP6C STX1B SUOX WDR24
Trunk fat percentage 2.05 13 9 27.3 -0.87 9.4e-05 AGBL4 BAI2 BDNF-AS CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MST1R NPM1 RERE RTEL1 SRR
Hand grip strength (right) 1.76 6 2 6.1 0.35 4.0e-01 ACTR1A GAPVD1 MAPKAP1 NOB1 NPM1 PPP6C
Townsend deprivation index at recruitment 3.25 2 0 0.0 0.00 1.0e+00 CTTNBP2 PPP6C
Current tobacco smoking 7.94 20 8 24.2 -0.99 1.7e-18 ACTR1A COQ5 CTTNBP2 DESI1 DPH2 GAPVD1 GTF3C6 KLC1 MAPKAP1 PIK3C2A PPP1R13B PPP6C RRP7A RTEL1 SEMA6D ST3GAL3 TDRD9 TLX1NB WBP1L XRCC3
Maternal smoking around birth 4.77 8 1 3.0 -1.00 6.3e-11 ACTR1A CASC10 DPH2 MST1R NAT6 PPP1R13B TDRD9 XRCC3
Fed-up feelings 1.95 5 2 6.1 -0.98 7.4e-05 AMIGO3 CCDC88B CTTNBP2 GPX1 MST1R
Taking other prescription medications 2.29 2 1 3.0 0.00 1.0e+00 CCDC88B MST1R
Age when periods started (menarche) 3.49 14 8 24.2 0.14 5.9e-01 AMIGO3 BDNF-AS DPH2 GAPVD1 GPX1 MAP2K5 MSH6 MST1R NAT6 NOB1 PPP6C RP3-467N11.1 ST3GAL3 SUOX
Heel bone mineral density (BMD) T-score, automated (left) 1.74 3 2 6.1 0.06 9.2e-01 GPX1 RERE TDRD9
Qualifications: CSEs or equivalent 1.76 1 0 0.0 0.00 1.0e+00 MST1R
High blood pressure 2.18 6 1 3.0 0.44 3.8e-01 FES MAP2K5 MAPKAP1 PDXDC2P SRR SUOX
Hayfever, allergic rhinitis or eczema 1.95 5 5 15.2 -0.29 6.4e-01 PGAP3 RERE RTEL1 SUOX WBP1L
Medication: Atenolol 1.25 1 1 3.0 0.00 1.0e+00 FES
Medication: Levothyroxine sodium 1.25 2 1 3.0 0.00 1.0e+00 CCDC88B SUOX
Sitting height 1.15 14 5 15.2 0.72 1.8e-03 AC110781.3 CPSF4 DPH2 FES GAPVD1 GLYCTK-AS1 MAPKAP1 MAST2 NCAM1 NOB1 PIK3C2A PPP6C WBP1L WDR24
Chronic bronchitis/emphysema (father) 1.94 1 0 0.0 0.00 1.0e+00 MAP2K5
High blood pressure (mother) 1.63 1 1 3.0 0.00 1.0e+00 FES
Body mass index (BMI) 3.56 26 17 51.5 -0.93 1.9e-13 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GLYCTK-AS1 GPX1 HYAL3 KLC1 LIN7C MAP2K5 MAST2 MEF2C MST1R NAT6 NOB1 NPM1 PHC2 PPP1R13B STX1B SUOX TDRD9 XRCC3
Impedance of leg (left) 2.47 25 11 33.3 0.54 2.9e-03 ACTR1A AMIGO3 BDNF-AS CADM2 COMMD7 CPSF4 FES GAPVD1 GLYCTK-AS1 GPX1 HYAL3 KLC1 LIN7C MEF2C MST1R NAT6 NPM1 PHC2 PIK3C2A PPP1R13B PPP6C SEMA6D SUOX TDRD9 XRCC3
Leg predicted mass (left) 1.99 19 10 30.3 -0.27 2.5e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 DESI1 GAPVD1 GPX1 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 PPP6C STX1B SUOX WDR24
Trunk fat mass 2.13 14 8 24.2 -0.92 2.5e-06 AGBL4 BAI2 BDNF-AS CADM2 CASC10 CPSF4 LIN7C MAP2K5 MST1R NPM1 PHC2 RERE RTEL1 STX1B
Waist circumference 2.76 15 11 33.3 -0.91 1.8e-06 AGBL4 BAI2 BDNF-AS CADM2 CASC10 CPSF4 KLC1 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 STX1B XRCC3
Past tobacco smoking 9.48 44 15 45.5 0.99 3.5e-39 AC110781.3 ACTR1A AMIGO3 CADM2 CASC10 CCDC167 CELF2 COMMD7 CPSF4 CTD-3025N20.3 CTTNBP2 DPH2 ELOVL7 GAPVD1 GPX1 GTF3C6 HAX1 HYAL3 LIN7C LRPPRC MAP2K5 MAPKAP1 MSH6 NAT6 NCAM1 NOB1 NPM1 NRXN2 PDXDC2P PGAP3 PHC2 PPP6C RP11-89K21.1 SDK1 SRR STX1B SUOX TANK TDRD9 TMEM161B-AS1 TOP2B WBP1L WDR24 XRCC3
Alcohol usually taken with meals 2.74 3 0 0.0 0.00 1.0e+00 ACTR1A CTTNBP2 DPH2
Nervous feelings 2.60 7 3 9.1 0.97 4.0e-04 ACTR1A AGBL4 CADM2 GLYCTK-AS1 MAP2K5 SRR TMEM161B-AS1
Frequency of tenseness / restlessness in last 2 weeks 2.05 2 0 0.0 -0.05 9.5e-01 GPX1 MST1R
Hearing difficulty/problems with background noise 2.00 3 1 3.0 0.21 7.9e-01 KLC1 WBP1L XRCC3
Had other major operations 1.74 1 0 0.0 0.00 1.0e+00 RP11-382A20.2
Forced vital capacity (FVC) 1.52 9 2 6.1 0.56 1.2e-01 AMIGO3 CASC10 GAPVD1 GPX1 HAX1 NOB1 PPP6C RTEL1 WBP1L
Heel bone mineral density (BMD) T-score, automated (right) 1.79 3 2 6.1 0.33 5.2e-01 GPX1 RERE TDRD9
Ever unenthusiastic/disinterested for a whole week 2.12 2 0 0.0 0.39 6.1e-01 AMIGO3 GPX1
Qualifications: None of the above 3.81 16 8 24.2 -0.97 3.0e-10 ACTR1A AMIGO3 BAI2 CELF2 DPH2 ELOVL7 GPX1 HYAL3 MEF2C MST1R NAT6 SEMA6D ST3GAL3 SUOX TANK WDR24
Financial difficulties in last 2 years 2.97 3 0 0.0 -1.00 4.4e-03 KLC1 PPP1R13B XRCC3
Mouth/teeth dental problems 2.78 5 1 3.0 1.00 1.2e-06 EPHX2 KLC1 PPP1R13B TDRD9 XRCC3
Heart attack 1.88 2 0 0.0 0.00 1.0e+00 FES NOB1
Allergy 2.15 6 5 15.2 0.23 6.6e-01 PGAP3 RERE RTEL1 SUOX UNC119B WBP1L
Hayfever/allergic rhinitis (self-reported) 1.39 1 0 0.0 0.00 1.0e+00 SUOX
Medication: Ramipril 1.32 1 0 0.0 0.00 1.0e+00 FES
Medication: Simvastatin 1.07 1 1 3.0 0.00 1.0e+00 FES
Fluid intelligence score 2.49 8 3 9.1 0.97 6.9e-05 AMIGO3 CELF2 DPH2 MST1R PIK3C2A ST3GAL3 TANK TOP2B
Illnesses of siblings 1.80 1 0 0.0 0.00 1.0e+00 FES
Neuroticism score 2.06 5 0 0.0 -0.37 5.4e-01 CADM2 CELF2 CTTNBP2 PPP6C RERE
Weight 2.32 19 12 36.4 -0.64 3.1e-03 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GAPVD1 GPX1 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 PPP6C STX1B SUOX
Impedance of arm (right) 3.13 19 17 51.5 0.66 8.9e-04 ACTR1A AMIGO3 BDNF-AS CADM2 CASC10 GAPVD1 GLYCTK-AS1 GPX1 HYAL3 IMMP2L LIN7C MEF2C MST1R NAT6 PHC2 PIK3C2A RP3-467N11.1 SUOX USP14
Arm fat percentage (right) 2.74 19 13 39.4 -0.74 1.1e-04 AGBL4 BAI2 BDNF-AS CASC10 CPSF4 KLC1 LIN7C MAP2K5 MAST2 MST1R NOB1 NPM1 PPP1R13B RERE SEMA6D SRR STX1B TDRD9 XRCC3
Trunk fat-free mass 1.93 18 9 27.3 -0.25 2.9e-01 ACTR1A AGBL4 AMIGO3 BDNF-AS CADM2 DESI1 GAPVD1 GPX1 LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 SUOX WBP1L WDR24
Hip circumference 2.37 19 11 33.3 -0.59 7.3e-03 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GAPVD1 LIN7C MAP2K5 MST1R NAT6 NPM1 NRXN2 PHC2 PPP6C RTEL1 STX1B
Alcohol intake versus 10 years previously 2.33 4 2 6.1 -0.99 1.4e-02 DPH2 EPHX2 MST1R UNC119B
Father's age at death 1.96 1 0 0.0 0.00 1.0e+00 FES
Worrier / anxious feelings 2.22 6 2 6.1 0.99 2.7e-04 ACTR1A CADM2 DPH2 GLYCTK-AS1 NOB1 TMEM161B-AS1
Frequency of tiredness / lethargy in last 2 weeks 2.99 4 1 3.0 -0.67 1.5e-01 AMIGO3 GPX1 LIN7C XRCC3
Number of live births 1.50 1 0 0.0 0.00 1.0e+00 MST1R
Forced expiratory volume in 1-second (FEV1) 1.95 6 4 12.1 0.75 3.3e-02 AMIGO3 GAPVD1 GPX1 NOB1 PPP6C SUOX
Pulse rate 2.11 3 1 3.0 -0.10 8.5e-01 AMIGO3 GPX1 MAPKAP1
Qualifications: A levels/AS levels or equivalent 3.38 11 5 15.2 0.94 1.4e-05 ACTR1A AMIGO3 BAI2 CELF2 DPH2 GPX1 MST1R ST3GAL3 SUOX TANK WDR24
Mouth/teeth dental problems: Dentures 2.36 5 1 3.0 -0.99 1.9e-03 AMIGO3 EPHX2 MST1R PGAP3 PIK3C2A
Asthma 2.25 5 2 6.1 0.44 4.6e-01 CORO1C MAP2K5 PGAP3 RERE SUOX
Medication: Cholesterol lowering 1.17 1 1 3.0 0.00 1.0e+00 FES
Lung cancer (father) 2.13 1 0 0.0 0.00 1.0e+00 TDRD9
Illnesses of mother 1.54 1 1 3.0 0.00 1.0e+00 FES
Forced expiratory volume in 1-second (FEV1), Best measure 1.70 4 3 9.1 0.71 1.8e-01 AMIGO3 GPX1 NOB1 SUOX
Pulse wave Arterial Stiffness index 1.52 1 0 0.0 0.00 1.0e+00 PHC2
Impedance of arm (left) 3.23 20 15 45.5 0.82 2.3e-06 ACTR1A AGBL4 AMIGO3 BDNF-AS CADM2 CASC10 CPSF4 GAPVD1 GLYCTK-AS1 GPX1 HYAL3 LIN7C MEF2C MST1R NAT6 PHC2 PIK3C2A RP3-467N11.1 SUOX USP14
Arm fat mass (right) 2.81 22 10 30.3 -0.74 9.4e-05 AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 KLC1 LIN7C MAP2K5 MST1R NAT6 NOB1 NPM1 PHC2 PPP1R13B SEMA6D SRR STX1B SUOX TDRD9 XRCC3
Trunk predicted mass 1.92 18 9 27.3 -0.24 3.0e-01 ACTR1A AGBL4 AMIGO3 BDNF-AS CADM2 DESI1 GAPVD1 GPX1 LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 SUOX WBP1L WDR24
Standing height 1.20 19 12 36.4 0.68 5.0e-04 AMIGO3 COQ5 CPSF4 DESI1 GAPVD1 GLYCTK-AS1 GPX1 MAPKAP1 MAST2 NOB1 PHC2 PIK3C2A PPP6C TDRD9 TLX1NB UNC119B WBP1L WDR24 XRCC3
Exposure to tobacco smoke at home 2.51 3 0 0.0 0.00 1.0e+00 AMIGO3 GPX1 MST1R
Tense / 'highly strung' 1.90 2 1 3.0 0.00 1.0e+00 CADM2 RERE
Seen doctor (GP) for nerves, anxiety, tension or depression 2.77 2 0 0.0 0.00 1.0e+00 CTTNBP2 LINC00899
Hair/balding pattern: Pattern 4 1.08 1 1 3.0 0.00 1.0e+00 SRR
Birth weight of first child 1.74 2 2 6.1 0.00 1.0e+00 FES SUOX
Peak expiratory flow (PEF) 1.84 5 1 3.0 0.60 1.5e-01 CTTNBP2 GAPVD1 PPP6C RP11-382A20.2 TOP2B
Pulse wave reflection index 2.10 2 0 0.0 0.00 1.0e+00 HYAL3 NAT6
Ever highly irritable/argumentative for 2 days 2.23 2 0 0.0 0.00 1.0e+00 AMIGO3 MST1R
Qualifications: O levels/GCSEs or equivalent 2.29 2 0 0.0 0.00 1.0e+00 DPH2 MST1R
Medication: Paracetamol 2.62 2 1 3.0 -0.84 1.6e-01 CASC10 GPX1
Headache pain in last month 1.64 1 0 0.0 0.00 1.0e+00 GLYCTK-AS1
Medication for cholesterol, blood pressure or diabetes 1.75 1 1 3.0 0.00 1.0e+00 FES
Gout (self-reported) 1.57 2 1 3.0 0.00 1.0e+00 CCDC88B NRXN2
Hypothyroidism/myxoedema (self-reported) 1.43 3 1 3.0 0.00 1.0e+00 CCDC88B SUOX TANK
Medication: Amlodipine 1.39 1 1 3.0 0.00 1.0e+00 FES
Medication: Ventolin 100micrograms inhaler 1.50 1 1 3.0 0.00 1.0e+00 PGAP3
Birth weight 1.34 4 1 3.0 0.05 9.5e-01 FES LINC00899 SRR SUOX
Chronic bronchitis/emphysema (mother) 2.15 3 0 0.0 0.00 1.0e+00 MAP2K5 MST1R TOP2B
High blood pressure (siblings) 1.96 2 1 3.0 0.00 1.0e+00 FES TDRD9
Forced vital capacity (FVC), Best measure 1.47 7 2 6.1 0.63 1.3e-01 AMIGO3 CASC10 GPX1 HAX1 MSH6 NOB1 RTEL1
Body fat percentage 2.42 17 9 27.3 -0.89 2.3e-06 AGBL4 BAI2 BDNF-AS CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MAST2 MST1R NOB1 NPM1 RERE RTEL1 SRR STX1B TDRD9
Leg fat percentage (right) 3.04 18 11 33.3 -0.93 8.3e-09 AGBL4 AMIGO3 BAI2 BDNF-AS CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MAPKAP1 MAST2 MST1R NPM1 RERE RP11-122A3.2 RTEL1 STX1B WDR24
Arm fat-free mass (right) 2.23 21 12 36.4 -0.34 1.2e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CYP2D8P1 DESI1 GAPVD1 GPX1 IMMP2L LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 STX1B SUOX
Exposure to tobacco smoke outside home 2.89 5 1 3.0 -0.98 2.9e-03 ACTR1A CTTNBP2 LIN7C MST1R NAT6
Comparative body size at age 10 2.16 7 5 15.2 -0.58 1.7e-01 CADM2 HYAL3 LIN7C MAP2K5 MEF2C NAT6 SRR
Number of full brothers 2.30 2 0 0.0 0.00 1.0e+00 AMIGO3 GPX1
Worry too long after embarrassment 1.92 2 0 0.0 0.00 1.0e+00 GAPVD1 MAP2K5
Wheeze or whistling in the chest in last year 2.79 6 3 9.1 -0.99 2.6e-04 BAI2 BDNF-AS LIN7C MST1R PGAP3 RTEL1
Number of children fathered 1.53 1 0 0.0 0.00 1.0e+00 CADM2
Reason for reducing amount of alcohol drunk: Health precaution 1.46 1 0 0.0 0.00 1.0e+00 SUOX
Age at first live birth 3.16 7 2 6.1 0.89 1.1e-03 AMIGO3 BAI2 DPH2 GPX1 MST1R NAT6 WDR24
Shortness of breath walking on level ground 1.47 1 0 0.0 0.00 1.0e+00 COMMD7
Qualifications: College or University degree 4.33 18 12 36.4 0.93 6.5e-09 ACTR1A AMIGO3 BAI2 CASC10 CELF2 CTTNBP2 DPH2 GPX1 HYAL3 MST1R NAT6 RTEL1 SDK1 SEMA6D ST3GAL3 SUOX TANK WDR24
Medication for pain relief, constipation, heartburn 2.21 1 0 0.0 0.00 1.0e+00 COMMD7
Neck or shoulder pain in last month 2.10 3 0 0.0 0.00 1.0e+00 GPX1 MST1R SUOX
Medication: Blood pressure 1.72 1 1 3.0 0.00 1.0e+00 FES
Angina (self-reported) 1.52 1 1 3.0 0.00 1.0e+00 FES
Medication: Allopurinol 1.34 1 1 3.0 0.00 1.0e+00 NRXN2
Mean time to correctly identify matches 1.73 2 1 3.0 0.00 1.0e+00 AGBL4 COMMD7
Whole body fat mass 2.57 17 9 27.3 -0.91 5.4e-07 AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 RERE RTEL1 STX1B
Leg fat mass (right) 3.18 20 12 36.4 -0.91 3.2e-08 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GPX1 GTF3C6 LIN7C MAP2K5 MAST2 MST1R NAT6 NPM1 PHC2 RERE RTEL1 STX1B
Arm predicted mass (right) 2.25 20 15 45.5 -0.38 9.4e-02 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 DESI1 GAPVD1 GPX1 IMMP2L LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 STX1B SUOX
Pulse rate, automated reading 2.72 9 5 15.2 0.55 6.2e-02 AMIGO3 CPSF4 CTD-3025N20.3 GPX1 HYAL3 MAPKAP1 MSH6 NAT6 PGAP3
Alcohol intake frequency. 1.71 7 3 9.1 -0.29 5.2e-01 CADM2 MST1R PGAP3 RP11-89K21.1 SUOX TMEM161B-AS1 WDR24
Comparative height size at age 10 1.36 12 6 18.2 0.70 7.3e-03 AMIGO3 COQ5 GLYCTK-AS1 MAPKAP1 MAST2 PIK3C2A ST3GAL3 TDRD9 TLX1NB WBP1L WDR24 XRCC3
Suffer from 'nerves' 1.76 2 1 3.0 0.00 1.0e+00 CADM2 RERE
Overall health rating 3.11 9 3 9.1 -0.91 2.4e-04 AC110781.3 AMIGO3 GPX1 MAPKAP1 MST1R PPP6C SUOX TANK XRCC3
Chest pain or discomfort 2.10 1 0 0.0 0.00 1.0e+00 GPX1
Age at last live birth 2.60 4 2 6.1 -0.43 4.7e-01 AMIGO3 GPX1 MST1R NAT6
Leg pain on walking 1.74 1 1 3.0 0.00 1.0e+00 MST1R
Medication: Aspirin 1.28 1 0 0.0 0.00 1.0e+00 FES
Knee pain experienced in last month 1.89 2 0 0.0 0.00 1.0e+00 AC110781.3 MST1R
Hypertension (Self-reported) 2.19 6 1 3.0 0.40 4.3e-01 FES MAPKAP1 PDXDC2P RERE SRR SUOX
Illnesses of father: Heart disease 1.58 2 1 3.0 0.00 1.0e+00 CORO1C FES
Smoking status: Previous 6.01 16 3 9.1 -0.97 2.1e-10 ACTR1A CADM2 CASC10 COMMD7 GTF3C6 HYAL3 MSH6 NAT6 NCAM1 NOB1 PHC2 RP11-89K21.1 SDK1 STX1B SUOX WBP1L
Forced expiratory volume in 1-second (FEV1), predicted 1.08 2 0 0.0 0.00 1.0e+00 GLYCTK-AS1 WBP1L
Whole body fat-free mass 1.98 18 10 30.3 -0.25 3.0e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 DESI1 GAPVD1 GPX1 LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 SUOX WDR24
Leg fat-free mass (right) 1.85 16 10 30.3 -0.23 3.8e-01 ACTR1A AGBL4 BAI2 BDNF-AS CADM2 DESI1 GAPVD1 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 PPP6C SUOX WDR24
Arm fat percentage (left) 2.63 17 11 33.3 -0.71 5.9e-04 AGBL4 BAI2 BDNF-AS CASC10 CPSF4 KLC1 LIN7C MAP2K5 MST1R NOB1 NPM1 RERE SEMA6D SRR STX1B TDRD9 XRCC3
Average weekly red wine intake 1.98 1 0 0.0 0.00 1.0e+00 CADM2
Mood swings 2.03 6 0 0.0 -0.99 4.9e-05 AMIGO3 CCDC88B CELF2 CTTNBP2 GPX1 MST1R
Loneliness, isolation 2.14 1 0 0.0 0.00 1.0e+00 RERE
Long-standing illness, disability or infirmity 2.69 2 0 0.0 0.00 1.0e+00 KLC1 XRCC3
Friendships satisfaction 1.13 1 0 0.0 0.00 1.0e+00 DESI1
Qualifications: nursing, teaching 2.30 3 0 0.0 0.00 1.0e+00 BAI2 MEF2C MST1R
Asthma (self-reported) 2.32 5 2 6.1 0.45 4.5e-01 CORO1C MAP2K5 PGAP3 RERE SUOX
Osteoporosis (self-reported) 1.26 1 0 0.0 0.00 1.0e+00 CCDC88B
Medication: Aspirin 1.30 1 1 3.0 0.00 1.0e+00 FES
Illnesses of father: None of the above (group 1) 1.07 1 1 3.0 0.00 1.0e+00 FES
Smoking status: Current 7.98 26 6 18.2 -0.98 4.4e-23 ACTR1A AGBL4 COQ5 CORO1C CTTNBP2 CYP2D8P1 DESI1 DPH2 GAPVD1 GTF3C6 KLC1 MAPKAP1 NCAM1 PDXDC2P PIK3C2A PPP1R13B PPP6C RP11-89K21.1 RRP7A RTEL1 SEMA6D SRR ST3GAL3 TDRD9 TLX1NB XRCC3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.96 5 1 3.0 -0.73 1.6e-01 AMIGO3 GPX1 PGAP3 STX1B TOP2B
Whole body water mass 1.98 19 10 30.3 -0.26 2.7e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 DESI1 GAPVD1 GPX1 LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 STX1B SUOX WDR24
Leg predicted mass (right) 1.84 17 10 30.3 -0.24 3.5e-01 ACTR1A AGBL4 BAI2 BDNF-AS CADM2 DESI1 GAPVD1 LIN7C MAP2K5 MST1R NAT6 NPM1 PHC2 PPP6C STX1B SUOX WDR24
Arm fat mass (left) 2.81 21 10 30.3 -0.80 1.5e-05 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 KLC1 LIN7C MAP2K5 MST1R NAT6 NOB1 NPM1 PHC2 RERE SEMA6D STX1B TDRD9 XRCC3
Number of self-reported non-cancer illnesses 2.26 1 0 0.0 0.00 1.0e+00 TDRD9
Average weekly champagne plus white wine intake 1.99 3 0 0.0 0.00 1.0e+00 RERE SUOX WDR24
Miserableness 2.60 6 3 9.1 -0.99 1.9e-06 AMIGO3 CELF2 CTTNBP2 GPX1 MST1R TANK
Guilty feelings 1.96 1 0 0.0 0.00 1.0e+00 AMIGO3
Mother's age at death 2.15 1 0 0.0 0.00 1.0e+00 MAPKAP1
Medication: Blood pressure 1.55 1 1 3.0 0.00 1.0e+00 FES
Medication: Bendroflumethiazide 1.38 1 0 0.0 0.00 1.0e+00 FES
Medication: Paracetamol 2.44 3 1 3.0 -0.77 1.3e-01 CASC10 COMMD7 GPX1
Illnesses of father: High blood pressure 1.93 1 1 3.0 0.00 1.0e+00 FES
Ever smoked 8.81 32 12 36.4 -0.99 1.1e-29 AC110781.3 ACTR1A CADM2 CCDC167 COMMD7 CPSF4 CTTNBP2 ELOVL7 GAPVD1 GPX1 GTF3C6 HAX1 HYAL3 LINC00899 MAP2K5 MAST2 MSH6 NCAM1 NOB1 NRXN2 PDXDC2P PGAP3 PHC2 PPP6C RP11-89K21.1 SDK1 SRR STX1B TMEM161B-AS1 TOP2B WBP1L WDR24
Basal metabolic rate 2.06 20 10 30.3 -0.35 1.3e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 DESI1 GAPVD1 GPX1 LIN7C MAP2K5 MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 STX1B SUOX
Leg fat percentage (left) 3.01 18 11 33.3 -0.93 8.5e-09 AGBL4 AMIGO3 BAI2 BDNF-AS CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MAPKAP1 MAST2 MST1R NPM1 RERE RTEL1 STX1B TDRD9 WDR24
Arm fat-free mass (left) 2.27 19 14 42.4 -0.39 8.5e-02 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 DESI1 GAPVD1 GPX1 LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 STX1B SUOX
Number of operations (self-reported) 2.36 7 1 3.0 -0.99 3.6e-06 AMIGO3 CASC10 GPX1 HYAL3 MST1R NPM1 TANK
Average weekly beer plus cider intake 2.67 4 1 3.0 0.14 8.6e-01 BDNF-AS MST1R NAT6 RP11-89K21.1
Irritability 2.15 2 0 0.0 -0.39 6.1e-01 AMIGO3 GPX1
Risk taking 3.25 7 3 9.1 -0.95 2.4e-04 CADM2 KLC1 LINC00899 PPP1R13B RP11-89K21.1 TDRD9 XRCC3
Age started oral contraceptive pill 2.27 1 0 0.0 0.00 1.0e+00 IMMP2L
Diastolic blood pressure, automated reading 2.21 9 4 12.1 -0.12 7.6e-01 CASC10 FES MAP2K5 MAPKAP1 MST1R RERE RTEL1 SRR TDRD9
Ever depressed for a whole week 2.73 3 0 0.0 -0.99 4.3e-04 AMIGO3 GPX1 HYAL3
Vascular/heart problems diagnosed by doctor 2.28 5 1 3.0 -0.16 7.6e-01 FES MAP2K5 SRR SUOX XRCC3
Pain experienced in last month 2.90 7 2 6.1 -0.31 5.0e-01 COMMD7 GAPVD1 GPX1 MST1R NPM1 PPP6C SUOX
Supplements: Calcium 1.38 1 0 0.0 0.00 1.0e+00 HAX1
Heart attack/myocardial infarction (self-reported) 1.85 1 0 0.0 0.00 1.0e+00 FES
Heart disease (siblings) 1.26 1 0 0.0 0.00 1.0e+00 FES
Alcohol drinker status: Previous 2.07 1 0 0.0 0.00 1.0e+00 XRCC3
Pack years of smoking 3.20 4 0 0.0 -0.99 2.1e-03 AGBL4 GPX1 KLC1 XRCC3
Impedance of whole body 3.13 18 16 48.5 0.62 2.7e-03 ACTR1A AMIGO3 BDNF-AS CADM2 CPSF4 GAPVD1 GLYCTK-AS1 GPX1 HYAL3 LIN7C MEF2C MST1R NAT6 PHC2 PIK3C2A PPP6C RP3-467N11.1 SUOX
Leg fat mass (left) 3.14 19 13 39.4 -0.91 5.9e-08 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 CPSF4 GTF3C6 LIN7C MAP2K5 MAST2 MST1R NAT6 NPM1 PHC2 RERE RTEL1 STX1B
Arm predicted mass (left) 2.27 19 14 42.4 -0.37 1.1e-01 ACTR1A AGBL4 AMIGO3 BAI2 BDNF-AS CADM2 CASC10 DESI1 GAPVD1 GPX1 LIN7C MEF2C MST1R NAT6 PHC2 PPP6C RP3-467N11.1 STX1B SUOX

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 27 0.773 2.48
GTEx Adipose Visceral Omentum 12 0.589 2.53
GTEx Adrenal Gland 5 0.343 2.39
GTEx Artery Aorta 18 0.605 2.37
GTEx Artery Coronary 8 0.676 2.48
GTEx Artery Tibial 25 0.665 2.43
GTEx Brain Caudate basal ganglia 4 0.435 2.53
GTEx Brain Cerebellar Hemisphere 9 0.604 2.62
GTEx Brain Cerebellum 11 0.555 2.57
GTEx Brain Cortex 5 0.484 2.80
GTEx Brain Frontal Cortex BA9 5 0.541 2.72
GTEx Brain Hippocampus 3 0.571 2.73
GTEx Brain Hypothalamus 5 0.846 2.72
GTEx Brain Nucleus accumbens basal ganglia 5 0.577 2.57
GTEx Brain Putamen basal ganglia 4 0.641 2.41
GTEx Breast Mammary Tissue 13 0.658 2.55
GTEx Breast Mammary Tissue (Male) 4 0.335 2.26
GTEx Breast Mammary Tissue (Female) 13 0.790 2.40
GTEx Cells EBV-transformed lymphocytes 11 0.774 2.58
GTEx Cells Transformed fibroblasts 24 0.572 2.45
GTEx Colon Sigmoid 12 0.820 2.45
GTEx Colon Transverse 8 0.387 2.38
GTEx Esophagus Gastroesophageal Junction 10 0.692 2.44
GTEx Esophagus Mucosa 14 0.422 2.43
GTEx Esophagus Muscularis 14 0.433 2.50
GTEx Heart Atrial Appendage 10 0.633 2.45
GTEx Heart Left Ventricle 9 0.588 2.57
GTEx Liver 5 0.697 2.80
GTEx Lung 14 0.487 2.49
GTEx Muscle Skeletal 20 0.692 2.57
GTEx Nerve Tibial 21 0.486 2.39
GTEx Ovary 10 1.100 2.61
GTEx Pancreas 9 0.551 2.54
GTEx Pituitary 5 0.448 2.60
GTEx Prostate 5 0.600 2.64
GTEx Skin Not Sun Exposed Suprapubic 14 0.569 2.50
GTEx Skin Sun Exposed Lower leg 23 0.632 2.49
GTEx Small Intestine Terminal Ileum 2 0.433 2.62
GTEx Spleen 5 0.354 2.49
GTEx Stomach 9 0.619 2.51
GTEx Testis 11 0.348 2.39
GTEx Thyroid 21 0.525 2.49
GTEx Uterus 8 1.411 2.70
GTEx Vagina 2 0.315 2.18
GTEx Whole Blood 13 0.653 2.54
METSIM Adipose 23 0.499 2.35
NTR Blood 14 0.583 2.25
ROSMAP Brain Pre-frontal Cortex 19 0.433 2.43
YFS Blood 14 0.303 2.25
CommonMind Brain Pre-frontal Cortex 21 0.391 2.36
TCGA Breast Tumor 6 0.783 2.64
TCGA Breast Normal 18 0.428 2.14
TCGA Ovarian Tumor 8 0.274 2.18
TCGA Prostate Tumor 15 0.434 2.30